Mastering Internal Medicine for NEET-PG and INI-CET in Just 8 Days

October 25, 2024

Daily Targets

Study 7.5–8.5 h/day in 60–75‑min blocks (10–15‑min breaks).
Solve 150–180 MCQs/day (timed; mixed systems). Maintain an error log; write 1 rule learned per error.
Make 6–8 mini‑cards/day (algorithms, diagnostic ladders, drug doses/contraindications, red flags).
End with a 20‑min Rapid Recap (key scores, first‑line therapies, don’t‑miss emergencies).

Day 1 — Cardiovascular Medicine (IHD • HF • Arrhythmias • Valvular • Pericardial • Aorta • HTN)

Ischemic Heart Disease (IHD)

Syndromes: stable angina; NSTE‑ACS (UA/NSTEMI); STEMI; MINOCA/SCAD snapshot; Prinzmetal (vasospastic).
Risk & triage: typical vs atypical chest pain; hemodynamic instability red flags; TIMI/GRACE (concept); high‑risk ECG patterns (de‑Winter, Wellens idea).
ECG pearls: STEMI territories (II, III, aVF—RCA; V1–V4—LAD; I, aVL, V5–V6—LCx); posterior MI (V7–V9); RV‑MI (V4R); LBBB/Sgarbossa idea.
Biomarkers: troponin kinetics; false ± (renal failure, myocarditis, tachyarrhythmia, early sampling); serial delta.
Immediate bundle: O₂ if hypoxemic; analgesia; dual antiplatelet loading (concept); parenteral anticoagulant (UFH/LMWH concept); nitrate/BB cautions (RV‑MI, hypotension, acute HF); avoid NSAIDs.
Reperfusion: Primary PCI (door‑to‑balloon); thrombolysis window & absolute contraindications; rescue PCI; no lysis in NSTEMI; post‑PCI care (DAPT duration snapshot).
Secondary prevention: high‑intensity statin; ACEi/ARB/ARNI post‑MI concept; beta‑blocker; MRA in LV dysfunction; smoking cessation; cardiac rehab.
Mechanical complications: papillary muscle rupture (acute MR); VSD; free‑wall rupture → tamponade; LV aneurysm; post‑infarct pericarditis vs Dressler.

Heart Failure (HF)

Classification: HFrEF (≤40%), HFmrEF (41–49), HFpEF (≥50); NYHA I–IV; ACC/AHA A–D.
Etiologies/precipitants: ischemia; valvular; cardiomyopathy; tachyarrhythmia; infection; anemia/thyroid; drugs (NSAIDs, NDHP‑CCB in HFrEF); dietary salt/water.
HFrEF disease‑modifying set: ACEi/ARB or ARNI; evidence BB (metoprolol succinate/bisoprolol/carvedilol); MRA; SGLT2i; diuretics for congestion; hydralazine‑isosorbide (select); devices (ICD—EF threshold; CRT—QRS duration, LBBB pattern).
HFpEF: control BP; diuretics for volume; AF/ischemia management; SGLT2i benefit idea.
Acute HF: warm/cold • dry/wet profiles; IV loop diuretics ± vasodilators; inotropes if cold + hypoperfusion; NIV; ultrafiltration snapshot.
Cardiomyopathies: HCM/HOCM (dynamic murmur ↑ with Valsalva/standing; SCD risk; screen family); DCM (ischemic, viral, alcoholic); RCM (amyloid, hemochromatosis); tako‑tsubo idea.

Arrhythmias & Conduction

AF: rate vs rhythm; cardioversion anticoagulation concept; CHA₂DS₂‑VASc awareness; HAS‑BLED risk awareness; antiarrhythmic classes snapshot.
SVT: AVNRT/AVRT—vagal maneuvers; adenosine; WPW (avoid AV‑node blockers in AF + WPW; use procainamide/DF).
Ventricular: sustained monomorphic VT vs polymorphic/torsades (Mg); VF—defib + amiodarone concept.
Brady/blocks: sinus node dysfunction; Mobitz I vs II; complete heart block—temporary vs permanent pacing; reversible causes (ischemia, drugs, electrolytes).
Syncope: reflex vs orthostatic vs cardiac (arrhythmia, AS, HCM); high‑risk features → admit.

Valvular Heart Disease

Aortic stenosis: harsh ejection murmur radiating to carotids; severity cues (valve area/gradient idea); TAVI vs SAVR triggers.
Aortic/mitral regurgitation: acute vs chronic physiology; afterload reduction idea; surgery timing (LVESD/LVEF cues concept).
Mitral stenosis: opening snap, diastolic rumble; PMBV vs surgery; AF anticoagulation.
Endocarditis: Duke criteria idea; typical organisms; TTE vs TEE; surgical indications snapshot; prophylaxis basics.

Pericardial & Aortic Disease

Acute pericarditis: pleuritic/positional pain; friction rub; ECG stages; NSAID + colchicine.
Effusion/Tamponade: Beck triad; pulsus paradoxus; echo; urgent pericardiocentesis.
Constrictive pericarditis: Kussmaul sign; pericardial knock; etiologies (TB, post‑surgery); imaging.
Aortic dissection: tearing pain; pulse differential; CXR mediastinum; initial HR/BP control; Stanford A vs B overview.

Hypertension

Dx: office vs ABPM; white‑coat vs masked; staging.
Secondary causes: renal artery stenosis, hyperaldo, pheo, Cushing, OSA, coarctation, thyroid.
Tx ladder: thiazide/ACEi/ARB/CCB; CKD/DM preferences; pregnancy‑safe agents.
Hypertensive crisis: emergency (target‑organ damage) vs urgency; IV drug choices (nicardipine, labetalol, nitroprusside concept).

Day‑1 MCQs to practice: STEMI window; AF anticoagulation logic; HFrEF outcome drugs; AS severity; tamponade first step; aortic dissection first drug.

Day 2 — Respiratory Medicine (Asthma • COPD • Pneumonia • TB • Pleura • PE • ILD • Sleep)

Obstructive Airway Disease

Asthma: phenotype (allergic, eosinophilic); control vs severity; step‑up/down (ICS ± LABA/LTRA); spacer technique; exercise‑induced; pregnancy; aspirin‑exacerbated; acute exacerbation ladder (O₂, SABA, ipratropium, systemic steroids; Mg in severe).
COPD: GOLD concept; symptom/exacerbation groups; LAMA/LABA/ICS indications; AE‑COPD bundle (steroids, bronchodilators, antibiotics if purulent); O₂ target 88–92%; pulmonary rehab; vaccination.
Bronchiectasis: chronic purulent cough; hemoptysis; CT “signet‑ring”; airway clearance; colonization (Pseudomonas) & exacerbation approach.

Pneumonia & Other Infections

CAP vs HAP/VAP: typical vs atypical organisms; CURB‑65 idea; PSI awareness; indications for ICU; parapneumonic effusion/empyema (pH <7.2, low glucose → drain); aspiration patterns.
NTM (MAC): suspicion in bronchiectasis; test overview.

Tuberculosis (India Focus)

Pulmonary vs EPTB: lymph node, pleural, meningeal pointers; diagnostic ladder (smear/NAAT/CXR ± USG, CSF profile idea); steroid role in TBM/pericarditis idea.
Adverse effects: isoniazid neuropathy, rifampicin discoloration/hepatitis, pyrazinamide hyperuricemia, ethambutol optic neuritis (concept).

Pleural Disease

Effusion: transudate vs exudate (Light’s criteria); common causes; malignant effusion brief; diagnostic taps (protein, LDH, glucose, pH, ADA idea).
Pneumothorax: primary vs secondary; tension signs; needle decompression site; ICD indications; air leak basics.

Pulmonary Vascular & Interstitial

PE: Wells idea; age‑adjusted D‑dimer concept; CTPA; anticoagulation; thrombolysis in shock; contraindications snapshot.
ILD: IPF vs CTD‑ILD; HRCT patterns (UIP/NSIP idea); antifibrotics concept; oxygen/rehab.
Sarcoidosis: bilateral hilar LAD; uveitis; hypercalcemia idea; steroids.

Sleep & Critical Care

OSA: STOP‑BANG; CPAP benefits; sequelae (HTN, AF).
ARDS: Berlin idea; low tidal volume ventilation; prone position snapshot.

Day‑2 MCQs to practice: Asthma steps; COPD O₂ target; Light’s criteria; TB diagnostics; PE first test by probability; ILD HRCT clue; tension pneumothorax site.

Day 3 — Neurology (Stroke • ICH/SAH • Epilepsy • Headache • NMJ • Myopathy • Demyelination • Neuro‑Infections)

Cerebrovascular

Ischemic stroke/TIA: anterior vs posterior circulation signs; CT non‑contrast first; thrombolysis/thrombectomy concept; BP & glucose targets; antiplatelet vs anticoagulation scenarios (AF‑related stroke timing idea); carotid disease snapshot.
Lacunar syndromes: pure motor, pure sensory; lipohyalinosis idea.
ICH: BP control; reversal strategies (warfarin/DOACs); neurosurgery triggers.
SAH: thunderclap; nimodipine concept; aneurysm repair awareness; complications (vasospasm, SIADH‑like hyponatremia).

Seizures & Epilepsy

Classification: focal vs generalised; first‑line AEDs by syndrome; teratogenicity concept; status epilepticus sequence (benzo → levetiracetam/valproate/phenytoin idea → refractory measures).

Headache Disorders

Migraine: aura vs no aura; acute (triptans/NSAIDs) vs prophylaxis (beta‑blocker, topiramate, valproate).
Cluster: autonomic features; 100% oxygen + SC triptan; verapamil prophylaxis concept.
Tension‑type: features and basics.
Red flags: SNOOP.

NMJ, Neuropathy & Myopathy

Myasthenia gravis: crisis vs cholinergic; AChR/MuSK; therapy ladder (AChE inhibitors → steroids/IVIg/PLEX; thymectomy idea).
GBS: ascending weakness; albumino‑cytologic dissociation; IVIg/plasmapheresis; FVC/negative inspiratory force monitoring.
Peripheral neuropathies: diabetic, B12, hypothyroid, toxic (chemo), vasculitic; small‑fiber pointers; mononeuritis multiplex idea.
Myopathies: inflammatory (PM/DM—malignancy association idea), endocrine, statin‑related; CK elevation patterns.

Demyelinating/Degenerative

MS: dissemination in time/place; MRI; disease‑modifying therapy idea; NMO snapshot (opticospinal, AQP4 idea).
Parkinson disease: bradykinesia + rigidity/tremor; drug classes (levodopa, dopamine agonists, MAO‑B inhibitors); motor fluctuations; impulse control disorders idea.
Dementia: Alzheimer vs vascular; reversible causes (B12, hypothyroid, NPH) snapshot.

Neuro‑Infections & Space‑Occupying Lesions

Meningitis/encephalitis: empiric therapy concept; LP contraindications; TB meningitis clues (CSF pattern idea).
Ring lesions: neurocysticercosis vs tuberculoma vs toxoplasma (HIV) — imaging/clinical clues.

Day‑3 MCQs to practice: Thrombolysis timing; status sequence; MG vs cholinergic; GBS FVC monitoring; cluster vs migraine; ring‑enhancing lesion clue.

Day 4 — Gastroenterology & Hepatology (Hepatitis • ALF • Cirrhosis • Portal HTN • Biliary • IBD • Diarrhea • PUD • Pancreas)

Hepatology

Acute hepatitis/ALF: viral/drug/autoimmune features; encephalopathy & INR red flags; transplant criteria idea; cerebral edema risk.
Chronic hepatitis: HBV/HCV serology maps; fibrosis to cirrhosis; HCC surveillance idea.
Cirrhosis core: Child‑Pugh/MELD; Ascites (SAAG; diuretics; large‑volume paracentesis + albumin concept); SBP diag/treat (PMN threshold); HE (staging; precipitant search; lactulose/rifaximin); Varices (screening; acute bleed bundle—vasoconstrictor + antibiotics + endoscopic banding; secondary prophylaxis); HRS (types; albumin + vasoconstrictor concept).
Cholestatic: PBC (pruritus, AMA idea) vs PSC (beading MRCP; UC association) pointers.
Metabolic: Wilson (Kayser–Fleischer; low ceruloplasmin); hemochromatosis; NAFLD/NASH; A1AT deficiency.

Biliary & Gallbladder

Cholelithiasis/Cholecystitis/Choledocholithiasis: RUQ pain; Murphy sign; obstructive LFTs; cholangitis (Charcot triad/Reynolds pentad idea) — biliary drainage concept.

Pancreas

Acute pancreatitis: causes (I GET SMASHED idea); severity (Ranson/BISAP concept); fluids; early enteral nutrition; complications (pseudocyst, necrosis, infection); when to image.
Chronic pancreatitis: pain; exocrine insufficiency; diabetes; calcifications; fat‑soluble vitamin deficiency.

Gastroenterology (Luminal)

IBD: UC vs Crohn—distribution, depth, perianal disease; extra‑intestinal features; induction vs maintenance (5‑ASA in UC; steroids; immunomod/biologics); complications (toxic megacolon, fistulas/strictures).
Diarrhea: acute infectious vs chronic (osmotic/secretory/inflammatory/fatty); C. difficile pointers; malabsorption (celiac anti‑TTG; dermatitis herpetiformis idea).
Upper GI: PUD; H. pylori test/eradication concept; UGIB (Forrest idea) & stabilization priorities; functional dyspepsia vs alarm features.
IBS vs IBD: differentiating cues; Rome concept (awareness).

Day‑4 MCQs to practice: HBV serology; SAAG cutoff; SBP PMN threshold; UC vs Crohn; HE precipitants; pancreatitis severity; cholangitis first step.

Day 5 — Nephrology & Acid‑Base/Electrolytes (AKI • CKD • GN • Tubules • Stones • Transplant • Dysnatremias)

AKI & CKD

AKI: prerenal vs intrinsic vs postrenal; FeNa/urine indices idea; ultrasound for obstruction; AEIOU dialysis triggers; contrast‑AKI prevention basics.
CKD: staging; anemia (iron/ESA); CKD‑MBD (phosphate binders, calcimimetics, vitamin D); acidosis; vaccination (HBV, pneumococcus, influenza idea).

Glomerular Disease

Nephritic vs nephrotic hallmarks; RBC casts vs oval fat bodies.
Nephritic: IgA nephropathy (synpharyngitic); PSGN; RPGN (ANCA‑assoc; anti‑GBM); lupus nephritis classes (idea); complements pattern.
Nephrotic: Minimal change (steroid response); FSGS; Membranous (TE risk); diabetic nephropathy (albuminuria stages); amyloidosis snapshot.

Tubulo‑Interstitial & RTA

AIN/ATN: drug‑induced AIN (fever, rash, eosinophils); ATN labs (muddy brown casts); ischemic vs nephrotoxic.
RTA: Type I/II/IV map; causes; therapy ideas.

Stones & UTIs

Nephrolithiasis: Ca‑oxalate/uric acid/struvite/cystine; prevention (fluids, thiazide, citrate; allopurinol for uric acid); imaging choice; indications for urgent decompression.
UTI/pyelo: risk groups; pregnancy pointers; complications; recurrent UTI prevention snapshot.

Kidney Transplant (Exam Snapshot)

Rejection types: hyperacute/acute/chronic; basics of immunosuppression; opportunistic infections.

Electrolytes & Acid–Base

Hyponatremia: hypo‑/eu‑/hypervolemic; SIADH; correction limits; osmotic demyelination risk.
Hypernatremia: water deficit; safe correction rates.
Potassium: hyperK ECG & emergency kit (Ca → insulin+glucose → beta‑agonist → bicarbonate → K‑removers); hypoK causes.
Acid–base: metabolic acidosis/alkalosis; respiratory disorders; anion gap; delta gap; Winter equation idea.

Day‑5 MCQs to practice: AEIOU; MCD vs FSGS; SIADH vs hypovolemic hypoNa; hyperK sequence; RTA type; stone type clue; transplant rejection type.

Day 6 — Endocrinology (Diabetes • Thyroid • Adrenal • Pituitary • Calcium/Bone • Lipids)

Diabetes & Acute Emergencies

Types & diagnosis: T1DM vs T2DM; diagnostic cutoffs; oral drug classes (mechanism + key AEs); insulin regimens; sick‑day rules.
Complications: retinopathy, nephropathy, neuropathy screening; diabetic foot basics; BP & lipid targets.
DKA/HHS: diagnostic cutoffs; fluids → insulin → electrolytes sequence; resolution criteria; precipitant search.
GDM: screening idea; targets; postpartum follow‑up.

Thyroid

Hypothyroidism: primary vs central; dosing/TSH targets; myxedema coma snapshot.
Hyperthyroidism: Graves vs toxic multinodular vs thyroiditis; beta‑blocker; antithyroid drugs; radioiodine; thyroid storm basics.
Thyroid nodule: TSH → USG risk features → FNAC (Bethesda) → surgery vs observation idea.

Adrenal

Primary adrenal insufficiency: hyperpigmentation; Addisonian crisis management.
Cushing: screening tests (concept); localization (ACTH‑dep/indep) idea.
Primary hyperaldosteronism: resistant HTN; hypokalemia; screening with ARR (awareness).
Pheochromocytoma: triad; pre‑op alpha then beta rule.

Pituitary & Water Balance

Prolactinoma: dopamine agonists; visual field check idea.
Acromegaly: IGF‑1 screen; MRI; therapy overview.
DI vs SIADH: urine/plasma osmolality logic; water deprivation response snapshot.

Calcium/Bone & Lipids

Hypercalcemia: PTH‑mediated vs malignancy; fluids + bisphosphonate.
Hypocalcemia: tetany; QT prolongation; IV calcium.
Osteoporosis/osteomalacia: risk factors; bisphosphonate basics; vitamin D deficiency.
Dyslipidemia: statins and risk thresholds; familial hypercholesterolemia snapshot.

Day‑6 MCQs to practice: DKA sequence; thyroid nodule algorithm; Addison crisis first step; Cushing screen; pheo rule; hypercalcemia first therapy.

Day 7 — Hematology & Oncology (Anemias • Hemolysis • MPN/MDS • Leukemia/Lymphoma • Myeloma • Coagulation • Transfusion)

Anemias

Microcytic: IDA vs thal trait vs ACD—ferritin/TIBC/transferrin saturation patterns; Mentzer index; iron therapy dosing & monitoring.
Normocytic: ACD; acute blood loss; hemolysis; CKD; hypothyroid; marrow infiltration.
Macrocytic: B12 vs folate—neuro signs; MMA concept; drugs (methotrexate, hydroxyurea) causing macrocytosis.

Hemolysis

Intravascular vs extravascular clues; labs (LDH, bilirubin, haptoglobin); G6PD triggers (oxidants, infections); autoimmune hemolysis (DAT) warm vs cold; PNH snapshot; sickle cell crises basics.

Hematologic Malignancies

Acute leukemias: ALL vs AML (Auer rods); APL emergency idea (coagulopathy); tumor lysis basics.
Chronic leukemias: CML (BCR‑ABL hallmark); CLL snapshot (lymphocytosis, smudge cells idea).
MPN/MDS: PV (pruritus, JAK2), ET, myelofibrosis (tear‑drop cells); MDS cytopenias (IPSS concept).
Lymphomas: Hodgkin (B symptoms, RS cells) vs NHL (aggressive vs indolent); staging concept; bulky disease idea.
Plasma cell disorders: MGUS vs smoldering vs multiple myeloma (CRAB; lytic lesions; renal involvement) — basics of evaluation (serum protein electrophoresis, free light chain idea).

Coagulation/Platelets & Transfusion

Bleeding disorders: hemophilia vs vWD (mucosal bleeding; desmopressin concept).
Thrombosis: DVT/PE basics; HIT awareness (drop in platelets; stop heparin); antiphospholipid syndrome idea.
DIC vs TTP/HUS: fibrinogen/platelets; schistocytes; ADAMTS13 idea; plasma exchange in TTP concept.
Transfusion: products & indications; reactions (febrile non‑hemolytic, acute hemolytic, TRALI/TACO) — recognition.

Day‑7 MCQs to practice: IDA vs thal; B12 vs folate; DAT interpretation; CML hallmark; DIC vs TTP; APL emergency clue; HIT first step.

Day 8 — Infectious Diseases • Rheumatology • Toxicology

Infectious Diseases & Stewardship

Sepsis bundle: early recognition; blood cultures; broad‑spectrum antibiotics; lactate; fluids/vasopressors idea.
HIV: testing ladder; baseline labs (CD4, VL, hepatitis serology); OI prophylaxis snapshot; ART concept; IRIS awareness.
Febrile neutropenia: empiric coverage concept; red flags (hypotension, mucositis, pulmonary infiltrates).
Endocarditis/osteomyelitis: when to suspect; basic diagnostic approach.

India‑Relevant Infections

Dengue: phases; warning signs (abdominal pain, persistent vomiting, mucosal bleed, lethargy); fluids; avoid NSAIDs; Hct/platelet trend.
Malaria: falciparum vs vivax; severe features (AMS, acidosis, anemia); smear/antigen test overview; initial therapy concept.
Scrub typhus: eschar; transaminitis; doxycycline response.
Leptospirosis: conjunctival suffusion; renal/hepatic involvement; management snapshot.
Enteric fever: prolonged fever; relative bradycardia; complications idea.
Rabies: PEP ladder (wound wash; vaccine ± RIG concept); schedule awareness.
TB extrapulmonary: lymph node, pleural, meningeal snapshots.
Others: JE, chikungunya; kala‑azar (fever, splenomegaly); filariasis; strongyloides hyperinfection (steroids risk).

Rheumatology

Pattern approach: mono/oligo/poly; inflammatory vs degenerative.
RA: small‑joint symmetric; serologies; DMARDs concept; extra‑articular involvement.
SLE: criteria gist; immunologic tests; organ involvement; nephritis idea.
Spondyloarthropathies: axial features; enthesitis; HLA‑B27; uveitis; psoriasis/IBD associations.
Crystal arthropathies: gout (needle‑shaped, negative birefringence); pseudogout (rhomboid, positive); acute vs prophylaxis; drug triggers.
Vasculitis: GCA/PMR; ANCA‑associated (GPA/MPA); PAN; palpable purpura basics.

Toxicology & Bites/Stings (India)

Organophosphate: DUMBBELLS; atropine first + pralidoxime; endpoints (dry lungs, HR).
Methemoglobinemia: “chocolate blood”; methylene blue (if no G6PD deficiency).
Beta‑blocker/CCB overdose: brady/hypotension; glucagon/high‑dose insulin concept.
TCA/aspirin/acetaminophen: ECG/widened QRS; nomogram idea; NAC for acetaminophen.
Snake bite: neurotoxic vs hemotoxic features; ASV indications; monitoring.
Scorpion sting: autonomic storm snapshot.

Day‑8 MCQs to practice: Dengue warnings; malaria species; OI prophylaxis; RA vs SLE; OP poisoning first drug; ASV indication clue; scrub typhus hallmark.

Back to blog